Keeping blood pressure under control is critical. There’s a new option for tough cases
About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...
Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
Like many industries preparing for Donald Trump's second term as president, the prospects for the healthcare industry are a mixed bag. But headwinds, like tariffs and drug pricing, are clearly blowing ...